LMPTP-IN-23

• CAT Number: I030929
• CAS Number: 1908414-82-3
• Molecular Formula: C28H36N4O
• Molecular Weight: 444.62
• Purity: 98%
• Synonyms: LMPTP-IN-23
• Solubility: Soluble in DMSO
• Appearance: Solid powder
• Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
• IUPAC Name: N,N-diethyl-4-[4-(3-piperidin-1-ylpropylamino)quinolin-2-yl]benzamide
• InChI: InChI=1S/C28H36N4O/c1-3-32(4-2)28(33)23-15-13-22(14-16-23)26-21-27(24-11-6-7-12-25(24)30-26)29-17-10-20-31-18-8-5-9-19-31/h6-7,11-16,21H,3-5,8-10,17-20H2,1-2H3,(H,29,30)
• InChIKey: XISMYRQHGUUMGY-UHFFFAOYSA-N
• SMILES: CCN(CC)C(=O)C1=CC=C(C=C1)C2=NC3=CC=CC=C3C(=C2)NCCCN4CCCCC4

LMPTP-IN-23（Cat No.:I030929）is a small molecule inhibitor that targets the protein tyrosine phosphatase (PTP) family, specifically inhibiting the activity of lymphoid phosphatase (LMPTP). LMPTP plays a crucial role in immune cell signaling, including the regulation of T-cell activation and cytokine production. By inhibiting LMPTP, LMPTP-IN-23 modulates immune responses, potentially offering therapeutic benefits in autoimmune diseases, inflammation, and cancer immunotherapy. It has shown promise in preclinical studies for its ability to enhance immune system function, making it a candidate for further investigation in immunomodulatory treatments and targeted cancer therapies.